Relay Therapeutics Ratios (2020-2025) | RLAY

Ratios Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
EBT Margin 890,800.00%721,560.00%-440,950.00%-4,431.09%-22,914.69%-9,134.08%-11,897.00%-14,808.11%-21,042.74%-24,470.64%-26,671.54%-41,698.67%-82,765.55%-260.82%8,349,600.00%-813.55%-1,003.46%-10,301.62%
EBIT Margin 923,966.67%732,140.00%-437,350.00%-4,454.31%-22,936.02%-9,157.66%-11,944.09%-14,969.21%-21,318.08%-24,968.60%-28,794.86%-44,768.58%-89,117.65%-291.95%9,219,600.00%-903.00%-1,105.21%-11,351.11%
EBITDA Margin 916,233.33%730,660.00%-439,550.00%-4,436.55%-22,923.58%-9,122.97%-12,090.65%-16,748.45%-21,774.25%-24,899.71%-25,507.51%-39,655.31%-83,011.76%-250.13%8,030,500.00%-822.91%-990.18%-10,424.82%
Operating Margin 923,966.67%732,140.00%-437,350.00%-4,454.31%-22,936.02%-9,157.66%-11,944.09%-14,969.21%-21,318.08%-24,968.60%-28,794.86%-44,768.58%-89,117.65%-291.95%9,219,600.00%-903.00%-1,105.21%-11,351.11%
Net Margin 890,800.00%4,277,340.00%-440,950.00%-4,431.09%-22,914.69%-9,134.08%-11,897.00%-14,808.11%-21,042.74%-24,470.64%-26,671.54%-41,698.67%-82,765.55%-260.82%8,349,600.00%-813.55%-1,003.46%-10,301.62%
FCF Margin 708,600.00%489,440.00%441,700.00%4,849.16%-3,405.33%-8,215.17%-7,158.20%-12,402.63%-16,150.68%-19,837.21%-23,476.28%-30,550.88%-58,910.92%-301.51%8,930,600.00%-520.67%-958.38%-8,166.47%
Efficiency
Assets Average 549.86M775.75M785.59M742.87M693.01M840.03M979.16M919.65M1,029.07M1,134.24M1,068.67M999.79M934.49M875.47M842.71M807.00M851.33M900.71M835.33M764.10M699.42M
Equity Average -213.87M244.07M738.41M748.04M675.66M594.81M734.45M869.89M810.80M889.70M974.99M916.82M846.77M794.25M765.19M748.88M713.75M760.30M808.33M749.44M693.37M636.68M
Invested Capital -202.35M-225.39M713.52M763.29M732.79M618.53M571.09M897.81M841.97M779.64M999.77M950.22M883.41M810.12M778.37M752.00M745.76M681.74M838.86M777.79M721.08M665.66M607.71M
Asset Utilization Ratio 0.000.000.000.000.000.000.000.000.000.000.000.030.030.040.040.010.010.010.010.01
Leverage & Solvency
Interest Coverage Ratio -0.01M-0.01M0.00M-0.01M-0.00M-0.03M
Equity Ratio -0.650.950.950.950.870.850.890.890.880.860.860.850.840.860.890.890.880.900.890.900.910.91
Times Interest Earned -0.01M-0.01M0.00M-0.01M-0.00M-0.03M
Valuation
Enterprise Value -70.34M-137.05M-559.28M-447.65M-262.72M-260.07M-228.56M-280.12M-119.44M-107.74M-354.64M-151.79M-161.28M-145.90M-151.33M-143.74M-152.87M-134.12M-152.36M-124.29M-93.54M-113.94M-91.56M
Return Ratios
Return on Sales 8,908.00%7,215.60%-4,409.50%-44.31%-229.15%-91.34%-118.97%-148.08%-210.43%-244.71%-266.72%-416.99%-827.66%-2.61%83,496.00%-8.14%-9.17%-34.50%-33.75%-10.03%-103.02%-35.52%
Return on Capital Employed -0.09%-0.33%-0.39%-0.45%-0.41%-0.31%-0.31%-0.28%-0.34%-0.39%-0.40%-0.44%-0.45%-0.47%-0.47%-0.44%-0.46%-0.47%-0.49%
Return on Assets -0.04%-0.09%-0.32%-0.38%-0.43%-0.39%-0.29%-0.28%-0.26%-0.30%-0.34%-0.35%-0.39%-0.39%-0.40%-0.41%-0.37%-0.40%-0.41%-0.42%
Return on Equity -0.04%-0.09%-0.35%-0.44%-0.50%-0.44%-0.33%-0.33%-0.30%-0.35%-0.41%-0.41%-0.45%-0.44%-0.45%-0.45%-0.42%-0.44%-0.45%-0.47%